AMSBIO has announced a new range of kits, media and reagents to assist in the development of cultured meat products - an exciting new area of food technology.

Cultured meat, also known as synthetic, artificial or in-vitro meat, is created by harvesting animal cells that are then placed in a bioreactor and fed with nutrients to help tissue growth. The driving force behind this rapidly expanding area of food technology is that the production of cultured meat requires far fewer animals to be farmed - so that a shift to cultured meat would reduce the production of greenhouse gases by livestock, as well as mitigating disease outbreaks (which can cross the species barrier to infect humans), and the welfare issues caused by industrialized farming and slaughter of animals.

However, there are challenges to scaling production of cultured meat to commercial levels. These include reducing the cost of cell media and growth factors, developing the best cell lines to create high quality cultured animal tissue as well as creating suitable extracellular matrices (ECM) for individual cell lines to enable efficient cell culture growth. In addition, there is the need to have bioreactors designed for industrial scale cultivation of different animal cells and edible scaffolding materials to enable large scale production of structured cultured meat products.

AMSBIO products for cultured meat research fall broadly into 3 areas. Firstly, to create the correct environment and stimuli for cultured cells. Secondly, standards and kits to test if these cells are behaving like the in vivo model and thirdly - cryopreservation media to archive cells for reference or future use. AMSBIO's growing range of high-quality products for pioneering cultured meat research includes skeletal muscle differentiation kits, recombinant extracellular matrices and cryopreservation media. Additionally, over the last 20 years, the company has established a vast biorepository containing animal DNA, RNA and tissue to act as positive controls, along with ELISA kits for quantification of meat proteins, such as collagen.

About AMS Biotechnology

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. 

For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.

Recent news from AMSBIO